Lilly migraine treatment meets main goal in late-stage studies

(Reuters) - Eli Lilly and Co said on Friday its experimental treatment met the main goal of reducing the number of monthly migraine headache days compared to a placebo in three late-stage studies.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Headache | Health | Migraine | Study